Adjuvo: adjuvant mitotane in patients with AC and low-intermediate risk of recurrence post-surgery
0 Visualizações
administrator
07/11/23
Jen-Jane Liu, MD, Oregon Health and Science University, Portland, OR, discusses the Adjuvo trial investigating mitotane in patients with adrenocortical carcinoma with low-intermediate risk of recurrence following surgery. The trial did not meet the primary endpoint of showing a benefit to adjuvant therapy in this patient population. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado